BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells.
about
Akacid medical formulation induces apoptosis in myeloid and lymphatic leukemic cell lines in vitro and in vivoRetinoic acid receptors α and γ are involved in antioxidative protection in renal tubular epithelial cells injury induced by hypoxia/reoxygenation.Therapeutic potential of Bcl-xL/Mcl-1 synthetic inhibitor JY-1-106 and retinoids for human triple-negative breast cancer treatment.
P2860
BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
BCL-xL/MCL-1 inhibition and RA ...... in human HL60 leukemia cells.
@ast
BCL-xL/MCL-1 inhibition and RA ...... in human HL60 leukemia cells.
@en
type
label
BCL-xL/MCL-1 inhibition and RA ...... in human HL60 leukemia cells.
@ast
BCL-xL/MCL-1 inhibition and RA ...... in human HL60 leukemia cells.
@en
prefLabel
BCL-xL/MCL-1 inhibition and RA ...... in human HL60 leukemia cells.
@ast
BCL-xL/MCL-1 inhibition and RA ...... in human HL60 leukemia cells.
@en
P2093
P2860
P1476
BCL-xL/MCL-1 inhibition and RA ...... y in human HL60 leukemia cells
@en
P2093
Jeremy L Yap
Jianshi Yu
Mariarita Perri
Maureen A Kane
Steven Fletcher
P2860
P304
P356
10.1016/J.YEXCR.2014.07.024
P407
P50
P577
2014-08-01T00:00:00Z